ADIM
NTES icon

Alpha DNA Investment Management’s NetEase NTES Stock Holding History

Alpha DNA Investment Management’s Portfolio NTES Stock Details NTES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300
Closed -$30K – 454
2021
Q1 		$30K Hold
300
– – 0.03% 222
2020
Q4 		$28K Buy
+300
New +$26.9K 0.03% 232

Other funds holding NTES

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpha DNA Investment Management's NTES Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of NetEase (NTES) in Q2 2021, closing a stake of 300 shares — an estimated $30K sold.

Alpha DNA Investment Management first reported a position in NTES in Q4 2020 and held it in 2 quarters. The position peaked at $30K in Q1 2021. 490 funds tracked by Wall St. Rank hold NTES as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining NetEase position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 300 NetEase shares in Q2 2021, an estimated $30K.
  • Alpha DNA Investment Management first reported a position in NetEase in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's NetEase position peaked at $30K in Q1 2021.
  • 490 funds tracked by Wall St. Rank held NetEase as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.